Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J. Gonzalez

Showing results (71-80 of 3,202) with videos related to

Pageof 321
Sort By:
The Journal of Clinical Investigation|August 2, 2021
Decreased vaccine protection of egg-based influenza vaccine in the elderly and nonhemagglutinin-focused immunityKaren J Gonzalez, Eva M Strauch
Nutrition and Cancer|June 16, 1999
Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification supportN J Gonzalez, L L Isaacs
Pharmacogenetics|January 1, 1995
The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesisP Fernandez-Salguero, F J Gonzalez
Annual Review of Pharmacology and Toxicology|January 13, 2006
Cytochrome P450 and xenobiotic receptor humanized miceFrank J Gonzalez, Ai-Ming Yu
Journal of Toxicology and Environmental Health|October 1, 1993
Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based diseaseF J Gonzalez, H V Gelboin
The Surgical Clinics of North America|August 21, 2016
Management of Truncal SarcomaJohn E Mullinax, Ricardo J Gonzalez
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 30, 2001
Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activityR J Gonzalez, J B Tarloff
Chemical Research in Toxicology|September 15, 2011
Why toxic equivalency factors are not suitable for perfluoroalkyl chemicalsJeffrey M Peters, Frank J Gonzalez
Clinical Pharmacokinetics|January 1, 1994
Pharmacogenetic phenotyping and genotyping. Present status and future potentialF J Gonzalez, J R Idle
DNA and Cell Biology|April 1, 1995
Role of the liver-enriched transcription factor HNF-1 alpha in expression of the CYP2E1 geneS Y Liu, F J Gonzalez
Pageof 321

Showing results (71-80 of 3,202) with videos related to

Sort By:
Pageof 321
The Journal of Clinical Investigation|August 2, 2021
Decreased vaccine protection of egg-based influenza vaccine in the elderly and nonhemagglutinin-focused immunityKaren J Gonzalez, Eva M Strauch
Nutrition and Cancer|June 16, 1999
Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification supportN J Gonzalez, L L Isaacs
Pharmacogenetics|January 1, 1995
The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesisP Fernandez-Salguero, F J Gonzalez
Annual Review of Pharmacology and Toxicology|January 13, 2006
Cytochrome P450 and xenobiotic receptor humanized miceFrank J Gonzalez, Ai-Ming Yu
Journal of Toxicology and Environmental Health|October 1, 1993
Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based diseaseF J Gonzalez, H V Gelboin
The Surgical Clinics of North America|August 21, 2016
Management of Truncal SarcomaJohn E Mullinax, Ricardo J Gonzalez
Toxicology in Vitro : an International Journal Published in Association with BIBRA|May 30, 2001
Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activityR J Gonzalez, J B Tarloff
Chemical Research in Toxicology|September 15, 2011
Why toxic equivalency factors are not suitable for perfluoroalkyl chemicalsJeffrey M Peters, Frank J Gonzalez
Clinical Pharmacokinetics|January 1, 1994
Pharmacogenetic phenotyping and genotyping. Present status and future potentialF J Gonzalez, J R Idle
DNA and Cell Biology|April 1, 1995
Role of the liver-enriched transcription factor HNF-1 alpha in expression of the CYP2E1 geneS Y Liu, F J Gonzalez
Pageof 321